Free Trial
→ Critical AI announcement set to ignite AI 2.0 (From Timothy Sykes) (Ad) Free NRSNW Stock Alerts

NeuroSense Therapeutics (NRSNW) SEC Filings & 10K Form

$0.39 -0.16 (-29.09%)
As of 08/1/2025 12:33 PM Eastern
Compare

Recent NeuroSense Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/01/2025
8:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2025
8:21 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2025
8:15 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2025
8:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
8:25 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/11/2025
3:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
04/11/2025
3:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
04/07/2025
4:25 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
01/06/2025
9:40 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:47 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/23/2024
8:04 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
10:06 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
1:42 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
12/12/2024
4:08 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
12/04/2024
7:32 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
3:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
11/22/2024
3:30 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
10/31/2024
3:59 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
10/01/2024
5:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
09/30/2024
3:53 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRSNW) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...
American Alternative | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Trump’s crypto advisor may have revealed the next big crypto opportunity
While investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...
Weiss Ratings | Sponsored
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...
Paradigm Press | Sponsored